Memory Loss Alzheimer S Disease And Dementia E Book

Now presented in full color, this updated edition of Memory Loss, Alzheimer's Disease, and Dementia is designed as a practical guide for clinicians that delivers the latest treatment approaches and research findings for dementia and related illnesses. Drs. Budson and Solomon - both key leaders in the field - cover the essentials of physical and cognitive examinations and laboratory and imaging studies, giving you the tools you need to consistently make accurate diagnoses in this rapidly growing area. Access in-depth coverage of clinically useful diagnostic tests and the latest treatment approaches. Case studies have been incorporated into the chapters and facilitate the management of both common and uncommon conditions. Comprehensive coverage of hot topics such as chronic traumatic encephalopathy, in addition to new criteria on vascular dementia and vascular cognitive impairment. Includes new National Institute on Aging-Alzheimer's Association and DSM-5 criteria for Alzheimer's Disease and Mild Cognitive Impairment. Learn how to use new diagnostic tests, such as the amyloid imaging scans florbetapir (Amyvid), flutemetamol (Vizamyl), and florbetaben (Neuraceq), which can display amyloid plaques in the living brains of patients. Updated case studies, many complete with videos illustrating common tests, clinical signs, and diagnostic features, are now incorporated into the main text as clinical vignettes for all major disorders. Brand-new chapters on how to approach the differential diagnosis and on primary progressive aphasia. Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, references, and videos from the book on a variety of devices. A practical guide mirroring clinical workflow intended to be used as a tool for accurately diagnosing dementia for all clinicians. Includes case studies and tests.

Memory Loss combines expert guidance, case studies, and diagnostic tests to help you effectively diagnose Alzheimer’s disease and other common dementias. Drs. Andrew E. Budson and Paul R. Solomon cover the essentials of physical and cognitive examinations, laboratory and imaging studies, and the latest treatment approaches. The practical text and diagnostic tests are the tools you need to consistently make accurate diagnoses. Confidently diagnose and treat Alzheimer’s disease and other common dementias through in-depth coverage of clinically useful diagnostic tests and the latest treatment approaches. Tap into the expertise of key leaders in the field for clear and practical guidance. See how to evaluate and manage both common and uncommon conditions with a full range of detailed case studies. Confirm your diagnoses easily with diagnostic tests. Carry the book with you and consult it conveniently thanks to its compact, portable format.

With a focus on the practical, day-to-day tools needed by neurologists, psychiatrists, geriatricians, and others who work with the elderly, Memory Loss, Alzheimer's Disease and Dementia, 3rd Edition, is an indispensable, easy-to-read resource in this growing area. Clinical experts Drs. Andrew Budson and Paul Solomon cover the essentials of physical and cognitive examinations and laboratory and imaging studies for dementia and related illnesses, giving you the guidance you need to make accurate diagnosis and treatment decisions with confidence. Provides in-depth coverage of clinically useful diagnostic tests and the latest research findings and treatment approaches. Incorporates real-world case studies that facilitate the management of both common and uncommon conditions. Contains new chapters on Alzheimer’s look-alikes and posterior cortical atrophy. Covers key topics such as chronic traumatic encephalopathy, primary age-related tauopathy (PART) and limbic-predominant, age-related TDP-43 encephalopathy (LATE), in addition to new criteria for dementia with Lewy bodies and posterior cortical atrophy. Includes current National Institute on Aging–Alzheimer's Association and DSM-5 criteria for Alzheimer’s disease and mild cognitive impairment. Demonstrates how to use diagnostic tests such as the amyloid imaging scans florbetapir (Amyvid), flutemetamol (Vizamyl), and florbetaben (Neuraceq), which can display amyloid plaques in the living brains of patients. Includes access to more than two dozen videos that illustrate common tests, clinical signs, and diagnostic features.

Rarely does one get an opportunity to experience the nightmare that is Alzheimer's Disease from the perspective of the person who has been stricken with it. In his book, "While I Still Can," Rick Phelps, the founder of "Memory People," an online Alzheimer's and dementia support group, changes all of that. Diagnosed with Early-Onset Alzheimer's Disease in his 50's, Rick decided it was time the veil was lifted. Throughout this book the reader is given a firsthand account of: the early signs that Rick experienced, the loneliness he felt during the denial period of family and friends, the terror that gripped his heart upon receiving the undeniable diagnosis and, after the diagnosis, how he and his loved ones have learned to cope with this mind robbing and fatal disease. A real page turner, "While I Still Can," affords an uncommon glimpse into the world of memory loss, while at the same time it tells the story of love, commitment, faith and courage in the face of a catastrophic disease.

This book is for individuals with mild cognitive impairment (MCI), their loved ones, and health care professionals who care for these patients. The text is loaded with up-to-date, scientifically substantiated knowledge about what MCI is, how it affects people, and how to take a proactive approach to health and wellbeing for living with MCI.

Alzheimer's Disease: Lifecourse Perspectives on Risk Reduction summarizes the growing body of knowledge on the distribution and causes of Alzheimer’s disease (AD) in human populations, providing the reader with knowledge on how we define the disease and what its risk and protective factors are in the context of a life-course approach. At the conclusion of the book, the reader will understand why Alzheimer’s disease likely begins at conception, then progresses through early-life and adult risk factors that ultimately impact the balance between pathologic insults in the brain and the ability of the brain to modify disease symptoms. In contrast to edited volumes that may have little cohesion, this book focuses on an integrated life-course approach to the epidemiology of dementia, in particular, Alzheimer’s disease. Reviews the current science surrounding Alzheimer’s disease Provides a primer of foundational knowledge on the disease's epidemiology and biostatistics Utilizes a life-course approach, providing a novel and integrated view of the evolution of this illness from genes to brain reserve Uses the ‘threshold model’—a theory first described by Dr. Mortimer and widely accepted today—which incorporates the idea of risk factors for the pathology and expression of the disease Proposes that improving brain health through modifiable behaviors can delay disease onset until a later age Examines the future of prevention of Alzheimer’s disease, a subject of great current interest

Dementia represents a major public health challenge for the world with over 100 million people likely to be affected by 2050. A large body of professionals is active in diagnosing, treating, and caring for people with dementia, and research is expanding. Many of these specialists find it hard to keep up to date in all aspects of dementia. This book helps solve that problem. The new edition has been updated and revised to reflect recent advances in this fast-moving field.